Globe Life (NYSE:GL – Get Free Report) updated its FY 2027 earnings guidance on Friday. The company provided EPS guidance of 16.100-17.100 for the period, compared to the consensus estimate of 16.510. Globe Life also updated its FY 2026 guidance to 15.350-15.650 EPS.
Globe Life Trading Down 6.1%
GL traded down $10.35 during mid-day trading on Friday, reaching $158.06. The stock had a trading volume of 305,832 shares, compared to its average volume of 541,981. The firm’s fifty day simple moving average is $170.48 and its two-hundred day simple moving average is $167.25. The stock has a market capitalization of $12.15 billion, a P/E ratio of 10.50 and a beta of 0.44. Globe Life has a 52 week low of $127.85 and a 52 week high of $191.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07.
Globe Life (NYSE:GL – Get Free Report) last released its earnings results on Wednesday, October 21st. The company reported $4.84 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.90 by ($0.06). The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.81 earnings per share. On average, equities analysts predict that Globe Life will post 15.70 EPS for the current year.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s payout ratio is currently 8.76%.
Globe Life announced that its board has approved a share repurchase program on Monday, August 10th that allows the company to repurchase $2.50 billion in outstanding shares. This buyback authorization allows the company to purchase up to 17.7% of its stock through open market purchases. Share buyback programs are generally a sign that the company’s board believes its stock is undervalued.
Analyst Ratings Changes
GL has been the subject of a number of recent analyst reports. Jefferies Financial Group upped their price objective on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Piper Sandler cut Globe Life from an “overweight” rating to a “neutral” rating and set a $165.00 target price on the stock. in a report on Friday. Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday. UBS Group set a $165.00 price target on Globe Life in a research note on Friday. Finally, TD Cowen cut their price target on shares of Globe Life from $225.00 to $215.00 and set a “buy” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $182.60.
View Our Latest Analysis on GL
Insiders Place Their Bets
In other news, EVP Robert Hensley sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the sale, the executive vice president owned 12,384 shares of the company’s stock, valued at $2,106,146.88. This trade represents a 44.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Thomas Kalmbach sold 21,000 shares of Globe Life stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the transaction, the chief financial officer owned 50,568 shares in the company, valued at $9,105,274.08. This trade represents a 29.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 143,650 shares of company stock valued at $25,793,717 over the last ninety days. 2.11% of the stock is owned by insiders.
Trending Headlines about Globe Life
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Globe Life reported third-quarter revenue of approximately $1.60 billion, above the $1.56 billion analyst consensus, with revenue up 5.5% year over year. Operating EPS increased to $4.84 from $4.81 a year earlier. Globe Life third-quarter 2026 results
- Positive Sentiment: Management is targeting $850 million to $950 million in parent excess cash flow for 2027, which could support capital returns, debt reduction or other shareholder-friendly actions. The company projects 2027 EPS of $16.10 to $17.10, a range that includes the $16.51 consensus estimate. Globe Life 2027 outlook
- Neutral Sentiment: The company’s 2027 EPS guidance of $16.10 to $17.10 implies continued earnings growth, but the broad range suggests uncertainty around operating performance and future underwriting results.
- Negative Sentiment: Third-quarter operating EPS of $4.84 missed estimates ranging from $4.87 to $4.90. Weaker underwriting income and higher expenses offset gains from increased premiums and investment income. Globe Life Q3 earnings miss
- Negative Sentiment: Globe Life cut its FY 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Reports also cited losses at Evry Health as a factor pressuring the full-year guidance. Evry Health losses and Globe Life guidance
- Negative Sentiment: The quarter included a reported underwriting loss of about $6.4 million, raising investor concerns about claims trends, expense control and the company’s ability to convert premium growth into profits. Globe Life underwriting loss analysis
About Globe Life
Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.
The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.
Read More
- Five stocks we like better than Globe Life
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
- Capital One Earnings: After a Double Beat the Rally Is On
- Tractor Supply’s Q3 Beat Plants the Seeds for a Stock Rebound
- WD-40 Could Reward Patient Investors—Here’s Why
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
